Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1999-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/JAC/43.SUPPL_2.69PMID 10382878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Onset of action under antidepressant treatment

  1997cited by this paper
• In vitro activity of BAY 12-8039, a new fluoroquinolone

  1997cited by this paper
• Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing.

  1997cited by this paper
• Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect

  1997cited by this paper
• In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

  1996cited by this paper
• Variability in Gastric pH and Delayed Gastric Emptying in Yucatan Miniature Pigs

  1994cited by this paper
• Physiological Parameters in Laboratory Animals and Humans

  1993cited by this paper
• Correlation of the Gastric Emptying of Nondisintegrating Tablets with Gastrointestinal Motility

  1991cited by this paper
• The estimation of moments: A technical note

  1989cited by this paper
• An inequality-constrained least-squares deconvolution method

  1989cited by this paper
• The Anatomy of the Domestic Animals

  1983cited by this paper
• MANUAL OF SYMBOLS, EQUATIONS & DEFINITIONS IN PHARMACOKINETICS

  1982cited by this paper
• Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics

  1982cited by this paper
• Noncompartmental determination of the steady-state volume of distribution.

  1979cited by this paper
• Statistical moments in pharmacokinetics

  1978cited by this paper
• Patterns of gastric electrical and motor activity in miniature pigs.

  1976cited by this paper
• Glomerular filtration.

  1974cited by this paper
• Quantitative Relations in the Physiological Constitutions of Mammals.

  1949cited by this paper

• A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model

  2026cites this paper
• Toward optimal moxifloxacin dosing in tuberculous meningitis: a translational physiologically based pharmacokinetic modeling approach

  2025cites this paper
• Clinical Characteristics, Diagnosis, and Outcomes of Moxifloxacin-Associated Bilateral Acute Iris Transillumination

  2025cites this paper
• The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs.

  2025cites this paper
• A modeling-based framework to evaluate forgiveness of TB drug combinations in a BALB/c relapsing mouse model

  2025cites this paper
• Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone.

  2024cites this paper
• Virtual clinical QT exposure-response studies - A translational computational approach.

  2024cites this paper
• mproving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment.

  2024cites this paper
• A “one‐step” approach to heart rate correction and statistical analysis applied to conscious dog QTc studies

  2024influential citation
• Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures

  2024cites this paper
• Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

  2023cites this paper
• Bilateral Acute Iris Transillumination Syndrome after Topical Moxifloxacin/Dexamethasone Initially Misdiagnosed as Uveitis: Case Report

  2023cites this paper
• Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases

  2023cites this paper
• Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

  2023cites this paper
• The New S7B/E14 Q&A Document Provides Additional Opportunities to Replace the Thorough QT Study

  2023cites this paper
• Comparing the sensitivity of cross-over and parallel study designs for QTc assessment: An analysis based on a single large study of moxifloxacin in 48 nonhuman primates.

  2023cites this paper
• Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation.

  2023cites this paper
• Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones

  2022cites this paper
• Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis

  2022cites this paper
• Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection

  2022cites this paper
• Characterisation of intravenous pharmacokinetics in Göttingen minipig and clearance prediction using established in vitro to in vivo extrapolation methodologies

  2022influential citation
• Population Pharmacokinetics of Moxifloxacin in Children

  2022cites this paper
• Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness

  2021cites this paper
• Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans

  2021cites this paper
• Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis

  2021cites this paper
• Moxifloxacin Concentrations in the Knee Joint, Tibial Bone, and Soft Tissue When Combined with Rifampicin

  2021cites this paper
• Effects of rifampicin on moxifloxacin concentrations in porcine cervical spine: a randomized microdialysis study.

  2020cites this paper
• Pharmacokinetics

  2019cites this paper
• Bilateral acute iris transillumination (BAIT) syndrome: literature review

  2019cites this paper
• The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review

  2019cites this paper
• Part III: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for Fluid Resuscitation and Antimicrobial Therapy Endpoints.

  2019cites this paper
• Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke?

  2018cites this paper
• Sensitivity and Reliability of Halothane‐anaesthetized Microminipigs to Assess Risk of Drug‐induced Long QT Syndrome

  2017cites this paper
• New Paradigm for Translational Modeling to Predict Long‐term Tuberculosis Treatment Response

  2017cites this paper
• Decreased protein binding of moxifloxacin in patients with sepsis?

  2017cites this paper
• Application of a systems pharmacology model for translational prediction of hERG‐mediated QTc prolongation

  2016influential citation
• Concurrent Threshold Retinopathy of Prematurity and Abusive Head Trauma

  2016cites this paper
• Fast and Sensitive RP-HPLC—Fluorescence Method for the Quantitative Analysis of Moxifloxacin in Rat Plasma and Its Application to a Preclinical Pharmacokinetic Study

  2016cites this paper
• CSAHi study: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes -assessment of inter-facility and cells lot-to-lot-variability.

  2016cites this paper
• HPLC-VALIDATION OF MOXIFLOXACIN

  2016cites this paper
• Risk for uveitis with oral moxifloxacin: a comparative safety study.

  2015cites this paper
• Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities

  2015influential citation
• Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.

  2014cites this paper
• Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis.

  2014influential citation
• Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis

  2014cites this paper
• Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 1. Ciprofloxacin, Moxifloxacin, and Grepafloxacin

  2014cites this paper
• Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects

  2014cites this paper
• Integration of pharmacokinetic and pharmacodynamic indices of valnemulin in broiler chickens after a single intravenous and intramuscular administration.

  2014cites this paper
• Moxifloxacin hydrochloride.

  2014cites this paper
• Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human.

  2013cites this paper
• Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients

  2013cites this paper
• Human Organic Cation Transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as Disposition Pathways for Fluoroquinolone Antimicrobials

  2013cites this paper
• Rat poorly predicts the combined non-absorbed and presystemically metabolized fractions in the human

  2013cites this paper
• Effects of moxifloxacin on serum glucose concentrations in rats.

  2013cites this paper
• Applications of minimal physiologically-based pharmacokinetic models

  2012cites this paper
• Pregabalin‐ and topiramate‐mediated regulation of cognitive and motor impulsivity in DBA/2 mice

  2012cites this paper
• A Physiologically Based Pharmacokinetic Model of the Minipig: Data Compilation and Model Implementation

  2012cites this paper
• Correlation Between In Silico Physicochemical Characteristics of Drugs and Their Mean Residence Time in Human and Dog

  2012cites this paper
• Plasma Disposition of Conventional and Long-Acting Moxifloxacin in Sheep after Intravenous Administration

  2012cites this paper
• Évaluation biopharmaceutique des antibiotiques pour le traitement des infections pulmonaires

  2012cites this paper
• ELECTROCHEMICAL BEHAVIOUR OF FOURTH-GENERATION FLUOROQUINOLONE ANTIBACTERIAL DRUG MOXIFLOXACIN BY DC POLAROGRAPHY AND CYCLIC VOLTAMMETRY Research Article

  2012cites this paper
• ASSESSMENT OF THE ROLE OF SOLUTE CARRIER DRUG TRANSPORTERS IN THE SYSTEMIC DISPOSITION OF FLUOROQUINOLONES: AN IN VITRO - IN VIVO COMPARISON

  2012cites this paper
• High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis

  2012cites this paper
• Tissue lipids and drug distribution: dog versus rat.

  2012cites this paper
• Penetration of moxifloxacin into liver tissue.

  2012cites this paper
• Moxifloxacin Population Pharmacokinetics in Patients with Pulmonary Tuberculosis and the Effect of Intermittent High-Dose Rifapentine

  2012cites this paper
• Good Penetration of Moxifloxacin into Human Abscesses

  2012cites this paper
• Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters

  2012cites this paper
• Development of a single-step precipitation cleanup method for the determination of enrofloxacin, ciprofloxacin, and danofloxacin in porcine plasma

  2011cites this paper
• Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net Reabsorption

  2011cites this paper
• In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis.

  2011cites this paper
• Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net re-absorption

  2011cites this paper
• Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net re-absorption

  2011cites this paper
• Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats

  2011cites this paper
• Efficacy of a New Fluoroquinolone, JNJ-Q2, in Murine Models of Staphylococcus aureus and Streptococcus pneumoniae Skin, Respiratory, and Systemic Infections

  2011cites this paper
• Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration.

  2010cites this paper
• Prediction of human drug clearance from two species: a comparison of several allometric methods.

  2010cites this paper
• Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.

  2010cites this paper
• Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium

  2010influential citation
• Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.

  2010cites this paper
• Pharmacokinetics and Bioavailability of Moxifloxacin in Calves following Different Routes of Administrations

  2010cites this paper
• Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model

  2010cites this paper
• Penetration of moxifloxacin into rat mandibular bone and soft tissue

  2009cites this paper
• Role of fixed coefficients and exponents in the prediction of human drug clearance: how accurate are the predictions from one or two species?

  2009cites this paper
• Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens

  2009cites this paper
• Chapter 9 – Pharmacokinetics

  2009cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2009cites this paper
• Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo Simulation

  2009cites this paper
• Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects.

  2009cites this paper
• 10 years’ experience with the pneumococcal quinolone moxifloxacin

  2009cites this paper
• Pharmacokinetics and intramuscular bioavailability of difloxacin in dromedary camels (Camelus dromedarius).

  2009cites this paper
• Disposition kinetics and pharmacokinetics--pharmacodynamic integration of difloxacin against Staphylococcus aureus isolates from rabbits.

  2008cites this paper
• APLICACIÓN DE FLUOROQUINOLONAS EN MEDICINA VETERINARIA: CRITERIOS FARMACOCINÉTICOS Y FARMACOCINÉTICOS/FARMACODINÁMICOS (PK/PD)

  2008cites this paper
• Disposition kinetics of moxifloxacin in lactating ewes.

  2008cites this paper
• Moxifloxacin: rapid improvement in acute bacterial sinusitis

  2008cites this paper
• COMPARISON BETWEEN THE IN VITRO EFFICACY OF MOXIFLOXACIN AND AMOXICILLIN AGAINST LISTERIA MONOCYTOGENES

  2008cites this paper
• Allometric scaling of xenobiotic clearance: Uncertainty versus universality

  2008cites this paper
• Rapid Eradication of Listeria monocytogenes by Moxifloxacin in a Murine Model of Central Nervous System Listeriosis

  2008influential citation
• Handbook of Anti-Tuberculosis Agents

  2008cites this paper
• Comparison of Rifampicin and Moxifloxacin Efficacy in an Experimental Model of Animal Brucellosis

  2008cites this paper